Tullinge, Sweden

Tilmann Wurtz


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tilmann Wurtz

Introduction

Tilmann Wurtz is a notable inventor based in Tullinge, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of enamel matrix related polypeptides. With a total of 2 patents to his name, Wurtz's work has the potential to impact the treatment of hard tissue diseases.

Latest Patents

Wurtz's latest patents include groundbreaking inventions related to nucleic acids encoding enamel matrix related polypeptides. The first patent focuses on novel nucleic acid fragments that mediate contact between enamel and cell surfaces. This invention also encompasses expression vectors for the production of the protein, methods for producing the polypeptide, and compositions that include these polypeptides. Additionally, it outlines methods for treating various hard tissue diseases or disorders. The second patent mirrors the first, emphasizing the importance of these nucleic acid fragments and their applications in medical treatments.

Career Highlights

Tilmann Wurtz is currently associated with Biora AB, a company that specializes in innovative biotechnological solutions. His work at Biora AB has allowed him to further develop his inventions and contribute to advancements in dental and hard tissue health.

Collaborations

Wurtz has collaborated with notable colleagues such as Radim Cerny and Ivan Slaby. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in their field.

Conclusion

Tilmann Wurtz's contributions to biotechnology, particularly through his patents on enamel matrix related polypeptides, showcase his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for advancements in the treatment of hard tissue diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…